Nicholas Marshall - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Nicholas Marshall

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Nature Immunology|June 13, 2017

IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functionsChang-Han Lee, Gabrielle Romain, Wupeng Yan, et al.

Nature Biotechnology|July 17, 2018

Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzymeTodd A Triplett, Kendra C Garrison, Nicholas Marshall, et al.

Arxiv|January 14, 2026

First, do NOHARM: towards clinically safe large language modelsDavid Wu, Fateme Nateghi Haredasht, Saloni Kumar Maharaj, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Nature Immunology|June 13, 2017

IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functionsChang-Han Lee, Gabrielle Romain, Wupeng Yan, et al.

Nature Biotechnology|July 17, 2018

Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzymeTodd A Triplett, Kendra C Garrison, Nicholas Marshall, et al.

Arxiv|January 14, 2026

First, do NOHARM: towards clinically safe large language modelsDavid Wu, Fateme Nateghi Haredasht, Saloni Kumar Maharaj, et al.

Pageof 9